A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1992
11/25/1992	EP0515235A2 DNA sequences coding for protein components of african horsesickness virus
11/25/1992	EP0515228A2 Essential pure human parathyroid hormone
11/25/1992	EP0514970A1 Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers
11/25/1992	EP0514830A2 Methods and compositions of a preparation and use of a herpes protease
11/25/1992	EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use
11/25/1992	EP0514720A2 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/25/1992	EP0514691A2 Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it
11/25/1992	EP0514481A1 Merosin, nucleic acids encoding, fragments and uses thereof
11/25/1992	EP0514475A1 CYCLIC GnRH ANTAGONISTS
11/25/1992	EP0514464A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
11/25/1992	EP0514460A1 Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
11/25/1992	EP0514458A1 Assays and treatments for autoimmune diseases
11/25/1992	EP0514442A1 N-phenyl n-acetamido glycinamides, preparation method and drugs containing them.
11/25/1992	EP0348399B1 Sorbin and peptide derivatives which increase aborption by the mucous membranes
11/25/1992	CA2331239A1 Structure, production and use of heregulin
11/25/1992	CA2069027A1 Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers
11/24/1992	US5166331 Antibiotics, viricides, antiinflammatory agents, wound healing agents, cytostatics, anesthetics, cholinergics or adrenergics
11/24/1992	US5166322 Cysteine added variants of interleukin-3 and chemical modifications thereof
11/24/1992	US5166321 Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria
11/24/1992	US5166318 Anticoagulants
11/24/1992	US5166317 Neurotrophic factor
11/24/1992	US5166316 Polypeptides for genetic engineering
11/24/1992	US5166195 Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
11/24/1992	US5166192 Gastrointestinal disorders; administering nonapeptide
11/24/1992	US5166191 Hormones for cardiovascular disorders
11/24/1992	US5166190 Activan or inhibin polypeptides
11/24/1992	US5166143 Angiotensin converting enzyme inhibitors such as phosphonate substituted amino acids, imino acids, phosphinylalkanoyl prolines or phosphonamidate
11/24/1992	US5166136 Antagonist of P undecapeptides as antiinflammatory agents and analgesics and for skin disorders
11/24/1992	US5166135 Method for the control of pneumocystis carinii
11/24/1992	US5166134 Nasal administration of serine protease inhibitor such as antitrypsin and antichymotrypsin
11/24/1992	US5166133 Antideposit agents or antiinflammatory agents by administering microglobulins
11/24/1992	US5166132 Partial hydrolysis of casein
11/24/1992	US5166058 Proteins for treatment of bone and cartilage defects for wound healing and tissue repair
11/24/1992	US5166056 Recombinant trichosanthin and coding sequence
11/24/1992	US5166050 Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
11/24/1992	US5165931 Peptifluorin and neopeptifluorin
11/24/1992	US5165922 Treatment of breast cancer
11/24/1992	US5165921 Skin disorders or viricides
11/24/1992	CA1310794C Derivatives of bicyclic amino acids, a process for their preparation, agents containing them and their use
11/24/1992	CA1310793C Nor-statine and nor-cyclostatine polypeptides
11/23/1992	CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use
11/19/1992	EP0514367A2 Protein C-containing drug
11/19/1992	EP0514361A1 Galanin antagonist
11/19/1992	EP0514268A1 Substituted amino acid azetidinyl pyridone derivatives, their preparation and use as medicines
11/19/1992	EP0514210A2 GRF analogs
11/19/1992	EP0514207A2 Novel human neurokinin-1 receptor short form
11/19/1992	EP0514130A2 Bone acidic glycoprotein (BAG-75) for inhibiting bone resorption
11/19/1992	EP0513974A1 Novel benzo-fused lactams that promote the release of growth hormone
11/19/1992	EP0513861A1 Vaccine adjuvant comprising a tetra-polyol
11/19/1992	EP0513778A2 Hybrid monoclonal antibodies and compositions containing them
11/19/1992	EP0513675A1 New peptide compound and a process for the preparation thereof
11/19/1992	EP0513613A1 Novel polypeptides with affinity to lipopolysaccharides and their uses
11/19/1992	EP0513543A1 Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them.
11/19/1992	EP0513388A1 Peptide with activity of inhibiting cancer cell infiltration, composite thereof, and cancer metastasis inhibitor
11/19/1992	EP0513371A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same
11/19/1992	EP0513345A1 Therapeutic and diagnostic applications of fetal fibronectin
11/19/1992	EP0513336A1 New variants derived from interferons of type i, production process thereof and their applications
11/19/1992	EP0513334A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-$g(b) FOR BONE REPAIR
11/19/1992	EP0513316A1 Analytical tracers for cancer, particularly malignant breast cancer.
11/19/1992	EP0513242A1 Lipopolysaccharide binding opsonin and methods of use thereof
11/19/1992	EP0513201A1 Leukocyte-derived growth factor
11/19/1992	EP0513150A1 New method for treating immunodeficiency or neutropenia
11/19/1992	EP0513073A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES.
11/19/1992	EP0192660B1 Absorption enhancing agents
11/19/1992	DE4116256A1 Measurement of allele-specific peptide sequences from class I or II MHC
11/19/1992	DE4115910A1 Prodn. of native and stable immunoglobulin - by extraction form total globulin with aq. methanol at specified pH, to provide IgG as prophylactic agent
11/18/1992	WO1992020364A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth
11/18/1992	CN1066272A Process for preparation of anti-thrombin polypeptides
11/18/1992	CN1066193A Recursor form of boving growth hormone releasing factor and related dna compounds
11/18/1992	CN1066192A Pulmonary administration of granulocyte colony stimulating factor
11/18/1992	CA2103258A1 Cytokine receptor targeted molecules for treatment of neoplastic cell growth
11/18/1992	CA2068813A1 Hybrid monoclonal antibodies and compositions containing them
11/18/1992	CA2068372A1 Human neurokinin-1 receptor short form
11/17/1992	WO1992020372A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	US5164489 Protein growth factor useful in diagnosis and treatment of lung cancer
11/17/1992	US5164486 Method of inhibiting large cell formation
11/17/1992	US5164482 Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
11/17/1992	US5164481 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
11/17/1992	US5164414 Antitumor
11/17/1992	US5164388 Heterocyclic peptide renin inhibitors
11/17/1992	US5164375 Antifungal agent
11/17/1992	US5164373 Blodd-coagulation factor XIII
11/17/1992	US5164372 Treatment of respiratory disorders, inflammation, dermatitis
11/17/1992	US5164371 Inhibitors of human leukocytic elastase
11/17/1992	US5164370 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)
11/17/1992	US5164369 Asparagine, leucine, arginine, cysteine
11/17/1992	US5164368 Treatment for osteoporosis using growth hormone releasing factor (grf) in combination with parathyroid hormone (pth)
11/17/1992	US5164367 Method of using copper(ii) containing compounds to accelerate wound healing
11/17/1992	US5164366 Diabetes
11/17/1992	US5164317 Method for enhanced growth and proliferation of mast cells
11/17/1992	US5164196 Antitumor
11/17/1992	US5164181 Chymopapain
11/17/1992	CA2109315A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	CA2068853A1 Substituted carboxy amino azetidinyl pyridone derivatives; process for preparing the same and their use as drugs
11/17/1992	CA1310445C Derivatives of aminopimelic acid, process for their preparation and their application as medecines
11/17/1992	CA1310444C Cck8 derived peptides, their preparation, and pharmaceutical compositions containing them
11/17/1992	CA1310443C Glutamic acid derivatives, their salts, process of preparation, applications as medications, and compositions containing them
11/17/1992	CA1310286C Isolation of a gene encoding human thyrotropin beta subunit
11/17/1992	CA1310266C Thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
11/17/1992	CA1310264C Modified antibodies for enhanced clearance

1 ... 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 ... 3163